Your body was built to heal. Mesenchymal Stem Cells (MSCs) are the biological architects of that process — capable of regenerating damaged tissue, modulating runaway inflammation, and restoring cellular function in ways that conventional medicine simply cannot replicate.
Umbilical cord-derived MSCs represent the most potent, ethically sourced, and clinically studied form of stem cell therapy available today. Collected from donated umbilical cord tissue after healthy births — with full donor consent — these cells are young, highly active, and immunologically tolerant, meaning they can be administered without rejection risk.
MSCs are multipotent stromal cells — meaning they have the capacity to differentiate into multiple cell types including bone, cartilage, muscle, fat, and connective tissue. But their most clinically significant function isn’t differentiation. It’s signaling.
MSCs act as master coordinators of the body’s repair response. They migrate to sites of injury, suppress destructive inflammatory signals, stimulate local tissue regeneration, modulate the immune system, and secrete growth factors that activate the body’s own healing mechanisms. This is why MSC therapy produces results that go far beyond what anti-inflammatory drugs or surgery can achieve.
Donated umbilical cord tissue — collected post-birth with full consent
Neonatal — among the youngest, most potent MSCs available
Low immunogenicity — can be administered to any patient without rejection
Higher proliferation and differentiation capacity than patient’s own aged cells
No embryonic tissue involved — fully ethically sourced
• Osteoarthritis of the knee, hip, shoulder, and spine
• Cartilage degeneration and joint space narrowing
• Tendon and ligament tears partial and chronic
• Disc degeneration and spinal stenosis
• Post-surgical joint recovery
• Systemic inflammation driving chronic disease
• Autoimmune conditions with inflammatory components
• Chronic inflammatory pain unresponsive to standard care
• Neuroinflammation and cognitive decline
• Post-COVID recovery and long-haul syndrome
• Metabolic dysfunction and insulin resistance
• Age-related cellular deterioration and longevity optimization
Chait does not administer MSC therapy in isolation. Every MSC protocol is designed within his root cause framework — addressing the inflammatory, hormonal, and metabolic environment that either supports or undermines the regenerative process.
A stem cell that lands in a body still driven by chronic inflammation, insulin resistance, and hormonal suppression will underperform. Chait eliminates those barriers first — then deploys MSC therapy into a biological environment primed for maximum regenerative response.
Umbilical cord MSC therapy is not FDA-approved as a treatment for any specific disease or condition. This content is for educational purposes only and does not constitute medical advice. Results vary by individual. Evan Chait is a licensed Physical Therapist and Acupuncturist, not a medical doctor (MD). Always consult a qualified healthcare professional before pursuing any cellular therapy.
